Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure.

Kessarin ThanapiromTongluk TeerasarntipanSombat TreeprasertsukAshok ChoudhuryManoj K SahuRakhi MaiwallViniyendra PamechaRichard MoreauMamun Al MahtabYogesh Kumar ChawlaHarshad DevarbhaviChen YuQin NingDeepak AmarapurkarChundamannil E EapenSaeed Sadiq HamidAmna Subhan ButtDong Joon KimGuan H LeeAjit SoodLaurentious A LesmanaZaigham AbbasGamal ShihaDiana A PayawalMan-Fung YuenAlbert ChanGeorge LauJidong JiaSalimur RahmanBarjesh C SharmaOsamu YokosukaShiv Kumar Sarinnull null

Published in: Hepatology international (2021)

The 28-day and 90-day mortality rates of ACLF patients without cirrhosis were significantly higher than those with cirrhosis in alcoholic CLD. The presence of cirrhosis and its stage should be evaluated at baseline to guide for management. Thai Clinical Trials Registry, TCTR20191226002.

Keyphrases

liver failure
clinical trial
end stage renal disease
ejection fraction
hepatitis b virus
newly diagnosed
chronic kidney disease
prognostic factors
cardiovascular events
type diabetes
liver injury
risk factors
drug induced
coronary artery disease
phase iii